Search hospitals > Florida > Tampa
Saint Joseph's Hospital/Children's Hospital-Tampa
Claim this profileTampa, Florida 33607
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Solid Tumors
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Neuroblastoma
193 reported clinical trials
12 medical researchers
Summary
Saint Joseph's Hospital/Children's Hospital-Tampa is a medical facility located in Tampa, Florida. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Acute Lymphoblastic Leukemia, Neuroblastoma and other specialties. Saint Joseph's Hospital/Children's Hospital-Tampa is involved with conducting 193 clinical trials across 349 conditions. There are 12 research doctors associated with this hospital, such as Don Eslin, MD, Vijaya K. Gadiyaram, Roberto Diaz, and Ronica H. Nanda.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Top PIs
Don Eslin, MDSaint Joseph's Hospital/Children's Hospital-Tampa8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
60 reported clinical trials
117 drugs studied
Vijaya K. GadiyaramMorton Plant Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
26 drugs studied
Roberto DiazMoffitt Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
11 drugs studied
Ronica H. NandaMorton Plant Hospital6 years of reported clinical research
Studies Breast Cancer
Studies Brain Tumor
4 reported clinical trials
8 drugs studied
Clinical Trials running at Saint Joseph's Hospital/Children's Hospital-Tampa
Breast Cancer
Lung Cancer
Breast cancer
Cancer
Testicular cancer
Acute Lymphoblastic Leukemia
Colorectal Cancer
Leukemia
Brain Tumor
Melanoma
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
HER2-Targeted Therapy
for Breast Cancer
This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherapy with trastuzumab. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer cells. When trastuzumab or pertuzumab attach to HER2, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving 6 months of HER2-targeted therapy may work better than giving 12 months for the treatment of HER2+ breast cancer in patients that had a pCR after neoadjuvant chemotherapy with trastuzumab.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph's Hospital/Children's Hospital-Tampa?
Saint Joseph's Hospital/Children's Hospital-Tampa is a medical facility located in Tampa, Florida. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Acute Lymphoblastic Leukemia, Neuroblastoma and other specialties. Saint Joseph's Hospital/Children's Hospital-Tampa is involved with conducting 193 clinical trials across 349 conditions. There are 12 research doctors associated with this hospital, such as Don Eslin, MD, Vijaya K. Gadiyaram, Roberto Diaz, and Ronica H. Nanda.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.